Max Masucci
Stock Analyst at Roth MKM
(4.11)
# 1,651
Out of 5,090 analysts
170
Total ratings
43.4%
Success rate
9.1%
Average return
Main Sectors:
Stocks Rated by Max Masucci
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NAUT Nautilus Biotechnology | Reiterated: Buy | $3.5 → $4 | $2.73 | +46.52% | 3 | Oct 28, 2026 | |
| GH Guardant Health | Initiated Coverage: Buy | $53 → $200 | $178.80 | +11.86% | 19 | Oct 22, 2026 | |
| NTRA Natera | Initiated Coverage: Buy | $100 → $475 | $414.30 | +14.65% | 23 | Oct 22, 2026 | |
| RPID Rapid Micro Biosystems | Initiated Coverage: Buy | $3 | $0.7359 | +307.66% | 2 | Sep 29, 2026 | |
| BDSX Biodesix | Reiterated: Buy | $32 → $41 | $23.26 | +76.31% | 10 | Sep 25, 2026 | |
| CSTL Castle Biosciences | Reiterated: Buy | $40 → $50 | $37.16 | +34.55% | 21 | Sep 22, 2026 | |
| MASS 908 Devices | Reiterated: Buy | $13 → $14 | $11.25 | +24.44% | 4 | Sep 22, 2026 | |
| TKNO Alpha Teknova | Reiterated: Buy | $8 → $10 | $7.36 | +35.87% | 6 | Sep 22, 2026 | |
| XGN Exagen | Reiterated: Buy | $9 → $11 | $8.59 | +28.06% | 6 | Sep 22, 2026 | |
| BRKR Bruker | Reiterated: Hold | $75 → $79 | $57.07 | n/a | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $155 → $151 | $157.00 | n/a | 5 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $6.13 | n/a | 2 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $99 | $69.06 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 → $15 | $2.91 | n/a | 24 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $15.82 | n/a | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $10.90 | n/a | 2 | Sep 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.59 | n/a | 2 | Jun 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $1.53 | n/a | 1 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $39 | $1.19 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.13 | n/a | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $470 → $515 | $235.99 | n/a | 16 | Jul 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $0.0007 | n/a | 11 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $0.25 | $0.01 | n/a | 1 | Apr 2, 2020 |
Nautilus Biotechnology
Oct 28, 2026
Reiterated: Buy
Price Target: $3.5 → $4
Current: $2.73
Upside: +46.52%
Guardant Health
Oct 22, 2026
Initiated Coverage: Buy
Price Target: $53 → $200
Current: $178.80
Upside: +11.86%
Natera
Oct 22, 2026
Initiated Coverage: Buy
Price Target: $100 → $475
Current: $414.30
Upside: +14.65%
Rapid Micro Biosystems
Sep 29, 2026
Initiated Coverage: Buy
Price Target: $3
Current: $0.7359
Upside: +307.66%
Biodesix
Sep 25, 2026
Reiterated: Buy
Price Target: $32 → $41
Current: $23.26
Upside: +76.31%
Castle Biosciences
Sep 22, 2026
Reiterated: Buy
Price Target: $40 → $50
Current: $37.16
Upside: +34.55%
908 Devices
Sep 22, 2026
Reiterated: Buy
Price Target: $13 → $14
Current: $11.25
Upside: +24.44%
Alpha Teknova
Sep 22, 2026
Reiterated: Buy
Price Target: $8 → $10
Current: $7.36
Upside: +35.87%
Exagen
Sep 22, 2026
Reiterated: Buy
Price Target: $9 → $11
Current: $8.59
Upside: +28.06%
Bruker
Aug 4, 2023
Reiterated: Hold
Price Target: $75 → $79
Current: $57.07
Upside: n/a
Aug 2, 2023
Reiterated: Buy
Price Target: $155 → $151
Current: $157.00
Upside: n/a
Dec 13, 2022
Reiterated: Buy
Price Target: $17
Current: $6.13
Upside: n/a
Nov 15, 2022
Reiterated: Buy
Price Target: $5 → $99
Current: $69.06
Upside: n/a
Nov 9, 2022
Reiterated: Hold
Price Target: $18 → $15
Current: $2.91
Upside: n/a
Nov 3, 2022
Reiterated: Buy
Price Target: n/a
Current: $15.82
Upside: n/a
Sep 8, 2022
Reiterated: Buy
Price Target: n/a
Current: $10.90
Upside: n/a
Jun 23, 2022
Reiterated: Buy
Price Target: n/a
Current: $1.59
Upside: n/a
Nov 29, 2021
Initiated Coverage: Buy
Price Target: $28
Current: $1.53
Upside: n/a
Nov 5, 2021
Reiterated: Buy
Price Target: $32 → $39
Current: $1.19
Upside: n/a
Oct 14, 2021
Reiterated: Hold
Price Target: n/a
Current: $11.13
Upside: n/a
Jul 14, 2021
Reiterated: Buy
Price Target: $470 → $515
Current: $235.99
Upside: n/a
May 6, 2021
Reiterated: Buy
Price Target: $3.5
Current: $0.0007
Upside: n/a
Apr 2, 2020
Initiated Coverage: Buy
Price Target: $0.25
Current: $0.01
Upside: n/a